Effects Of 6 Weeks Of Treatment With Dapagliflozin, A Sodium-Glucose Cotransporter 2 Inhibitor, On Myocardial Function And Metabolism In Type 2 Diabetes Patients: A Randomized Placebo-Controlled Study
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要